Info Edge Share Price Extends Loss To Fifth Day; Stock Downgraded To Underperform At BofA — Check Target Price
Info Edge share price has been declining for five sessions. The stock fell 3.17% to Rs 1,364 apiece, the lowest level since July 21.
Info Edge shares fell for a fifth straight session on Wednesday after Bank of America downgraded the stock to underperform and reduced its target price, citing an unfavourable risk-reward profile and medium-term growth concerns.
BofA lowered its target price to Rs 1,360 from Rs 1,740 per share, implying a 4.9% downside from Tuesday’s closing price. The brokerage expects muted growth in the company’s key verticals and limited upside from its investment portfolio.
Revenue growth at Naukri, Info Edge’s core recruitment platform, has stabilised but is unlikely to pick up significantly, BofA said. While hiring by global capability centres remains resilient, broader hiring trends are weak. The brokerage projects Naukri’s revenue to grow 17–18% year-on-year in FY26 and FY27.
On 99acres, the property listings platform, BofA expects losses to continue narrowing, assuming the market remains a three-player segment. However, it does not foresee any major improvement in profit margins.
BofA also flagged limited potential from Info Edge’s investments in start-ups and revised down its medium-term earnings estimates by 2–5%. The report noted that generative AI may reduce demand for entry-level jobs, where Naukri has high exposure.
Info Edge stock has declined over the past week as analysts turned cautious on near-term growth prospects across its business lines.
Info Edge share price has been declining for five sessions. The stock fell 3.17% to Rs 1,364 apiece, the lowest level since July 21. It was trading 2.35% down at Rs 1,376.30 apiece as of 10:46 a.m., compared to a 0.13% decline in the NSE Nifty 50 index.
The stock declined 1.92% in 12 months and 20.72% on a year-to-date basis. Total traded volume so far in the day stood at 2.8 times its 30-day average. The relative strength index was at 40.56.
Out of 21 analysts tracking the company, 13 maintain a 'buy' rating, six recommend a 'hold,' and two suggest 'sell,' according to Bloomberg data. The average 12-month consensus price target implies an upside of 15.1%.
